Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
BrightView Holdings, Inc. faces risks from macroeconomic volatility, including inflation, potential recession, and supply chain disruptions affecting raw material costs like fuel and fertilizer. The company notes that economic downturns may lead customers to reduce spending on landscape services or perform maintenance in-house.
The 21Shares XRP ETF reported a net asset value of $159.7 million as of September 30, 2026, down from $247.7 million at year-end 2025. The Trust experienced a net decrease in net assets resulting from operations of $37.4 million for the nine months ended September 30, 2026, primarily driven by unrealized depreciation on its XRP holdings and cash redemptions.
Christian Sedor, CAO, sold 4,225 shares of Arhaus, Inc. at $15.09 a share, worth $63.8K in total on Nov 9, 2026. Shares held after the trade: 5,669 (-42.7%).
GrowGeneration reported Q3 2026 financial results, achieving positive GAAP net income of $0.2 million and expanding gross margins to 32.4%. The company also announced a 2026 Restructuring Plan involving the closure of 4-5 underperforming retail locations and workforce reductions to focus on its proprietary-brand business. Full-year 2026 revenue guidance was narrowed to a range of $163 million to $165 million.
Term
Q3 2026
“Our third-quarter results reflect the continued progress of GrowGeneration's transformation into a national commercial cultivation supply and proprietary-brand platform. We delivered $44.8 million in revenue, expanded gross margin to 32.4%, and generated $2.3 million in Adjusted EBITDA.”
Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer
“We are also continuing to take meaningful actions to improve our cost structure, including a strategic restructuring plan initiated in the fourth quarter. Store and other operating expenses declined approximately 12% year-over-year, and we are moving forward with four to five store closures in the fourth quarter, along with additional restructuring initiatives designed to further reduce fixed costs and improve operating efficiency.”
Darren Lampert, GrowGen’s Co-Founder and Chief Executive Officer
Alto Neuroscience reported financial results for the third quarter ended September 30, 2026, highlighting a cash position of $319.8 million following a $100 million financing. The company confirmed its clinical pipeline remains on track, with topline data for its PACE-1 trial in treatment-resistant depression expected in the second half of 2027.
“During the third quarter, we continued to advance our clinical programs and strengthened our financial position ahead of a milestone-rich 2027. PACE-1 remains on track, and our recent financing has enabled us to expand the ALTO-207 Phase 3 development plans to include both monotherapy and adjunctive trials, aimed at supporting a broad label in TRD.”
Amit Etkin, M.D., Ph.D., founder and chief executive officer
KLX Energy Services Holdings Investor Presentation
KLX Energy Services Holdings, Inc. filed a formal investor presentation deck as Exhibit 99.1 to its 8-K. The presentation provides a Q3 2026 company update for analysts and investors regarding its operational performance and strategic outlook. The filing was made under Items 2.02 and 7.01 of Form 8-K.
Goldman Sachs Private Credit Corp. held its 2026 Annual Meeting of Stockholders on November 6, 2026. Shareholders elected Katherine P. Uniacke and Timothy J. Leach as Class III directors to serve until 2029 and ratified the selection of PricewaterhouseCoopers LLP as the independent accounting firm for the fiscal year ending December 31, 2026.
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focusing on the development of CTIM-76 and CT-202, while winding down its CT-95 Phase 1 clinical trial. As of November 6, 2026, the company had 91,879,177 shares of common stock outstanding and is classified as a smaller reporting company and emerging growth company.
Bluerock Homes Trust reported a net loss of $8.48 million for the third quarter of 2026, with total revenues increasing to $19.20 million compared to $16.61 million in the prior year period. The company's total assets stood at $1.17 billion as of September 30, 2026, while it continued to experience net losses attributable to common stockholders of $3.14 million for the quarter.
Resideo Technologies reported Q3 2026 financial results, its first quarter following the spin-off of its ADI Global Distribution business. The company achieved 3% revenue growth to $727 million and used a $900 million dividend from the ADI separation plus cash on hand to repay $1.1 billion in gross debt.
Term
Q3 2026
“Resideo delivered top and bottom line third quarter results that were near the high end of our outlook ranges in our first quarter following the separation of ADI, underscoring our team’s continued strong execution. We achieved 3% revenue growth year-over-year across all sales channels and 6% growth year-over-year excluding OEM Security, driven by customer demand for our differentiated, non-discretionary products.”
Tom Surran, Resideo's President and CEO
“We remain focused on creating value for our customers with our differentiated products and services. That includes new AI-powered capabilities on our next-generation FORTIQ software platform, which delivers actionable intelligence that enhances customer productivity and optimizes the end-user’s experience.”
Kopin Corporation reported Q3 2026 financial results with revenue growing 52% year-over-year to $18.2 million. The company narrowed its operating loss to $0.5 million and highlighted a significant $18.6 million U.S. Army IBAS award for its MicroLED technology.
For the nine months ended September 30, 2026, the REIT reported a net loss of $5.1 million on total revenues of $43.0 million, compared to a net loss of $68,000 on $23.6 million in revenue for the same period in 2025. Total assets grew significantly to $866.4 million from $514.4 million at year-end 2025, driven by increased investments in real estate and real estate-related securities.
For the nine months ended September 30, 2026, EQT Exeter Real Estate Income Trust reported total revenues of $31.0 million and a net loss of $1.5 million. Total assets increased to $557.8 million from $541.3 million at year-end 2025, while the company continued to issue multiple classes of common stock to fund its real estate investment activities.
Revvity, Inc. reported total revenue of $728.9 million for the third quarter of 2026, a 4% increase compared to the same period in 2025. Net income for the quarter rose to $62.3 million, up from $46.7 million year-over-year, while the company continued to execute its share repurchase program, reducing outstanding common stock to approximately 111.6 million shares.
Achieve Life Sciences significantly strengthened its liquidity position, ending September 30, 2026, with $201.5 million in cash and marketable securities compared to $36.4 million at the end of 2025. The company is focused on its NDA resubmission for cytisinicline following a CRL and is currently involved in arbitration with its supplier, Sopharma.
AAON, Inc. announced that its Board of Directors has declared a regular quarterly cash dividend of $0.10 per share. The dividend is payable on December 17, 2026, to stockholders of record as of November 25, 2026.
Velo3D, Inc. reported a significant increase in total assets to $252.3 million as of September 30, 2026, driven by a rise in cash and cash equivalents to $75.7 million and a substantial increase in other assets. The company continues to focus on scaling its additive manufacturing solutions, particularly in the defense and aerospace markets, while managing its liquidity and debt obligations.
Chain Bridge Bancorp, Inc. is a bank holding company for Chain Bridge Bank, N.A., specializing in services for political organizations. The filing highlights risks related to deposit seasonality following the November 2026 elections and the company's dual-class stock structure controlled by the Fitzgerald Family.
Bionano Genomics reported total revenue of $8.28 million for the third quarter of 2026, a 12% increase year-over-year, while narrowing its quarterly net loss to $6.45 million compared to $8.50 million in 2025. The company's cash position remains tight, with total cash, cash equivalents, and investments decreasing significantly from $19.27 million at the end of 2025 to $8.17 million as of September 30, 2026.
Electromed, Inc. reported net revenues of $18.7 million for the quarter ended September 30, 2026, a 10.6% increase over the prior year, driven primarily by growth in the homecare market. Net income rose to $2.8 million from $2.1 million, while the company significantly increased its common stock repurchases to $4.3 million during the period.
Carlsmed, Inc. reported revenue of $56.6 million for the nine months ended September 30, 2026, a significant increase from $35.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $31.5 million for the first nine months of 2026 as operating expenses, particularly in sales, marketing, and general administration, increased substantially.
Kura Oncology reported total revenue of $22.8 million for Q3 2026, driven by the introduction of $13.9 million in product revenue. Despite this, the company recorded a net loss of $70.2 million for the quarter and $211.9 million for the first nine months of 2026, with total stockholders' equity declining significantly to $18.0 million from $174.1 million at year-end 2025.
Atara Biotherapeutics reported Q3 2026 financial results, highlighting a significant 83% year-over-year reduction in operating expenses and a net loss of $2.2 million. The company is focused on the FDA's March 31, 2027, PDUFA date for tab-cel, which if approved would trigger a $31 million milestone payment from Pierre Fabre Laboratories.
“The resubmission of the tab-cel BLA was an important milestone this quarter, and we remain focused on supporting Pierre Fabre Pharmaceuticals (PFP) toward a successful outcome. We continue to believe in tab-cel’s significant commercial potential in the U.S. In parallel, we are taking steps to control expenses with the goal of protecting and maximizing shareholder value while enhancing our strategic flexibility.”
Cokey Nguyen, President and Chief Executive Officer
Estee Lauder Companies Insider Paul J. Fribourg Sells $277K of Stock
Paul J. Fribourg sold 2,406 shares of Estee Lauder Companies Inc at $115.10 a share, worth $277K in total on Nov 9, 2026. Shares held after the trade: 323,922 (-0.7%).
Intelligent Protection Management Corp. reported Q3 2026 revenue of $11.0 million, a 75% increase year-over-year, driven by strong demand for cybersecurity and cloud infrastructure procurement. The company generated $5.6 million in operating cash flow and noted a 33% increase in core managed services revenue from non-affiliated customers.
Term
Q3 2026
“Financial results for the third quarter of 2026 reflected exceptional customer demand and continued execution of our growth strategy, resulting in total revenue increasing more than 75% to approximately $11.0 million compared to the third quarter of 2025.”
Jason Katz, Chairman and Chief Executive Officer
“Our balance sheet remains strong, providing the financial flexibility necessary to support organic growth initiatives while pursuing strategic opportunities that enhance our long-term growth profile.”
LightPath Technologies reported fiscal 2027 first quarter revenue of $20.8 million, a 38% year-over-year increase driven by a shift toward higher-value cameras and optical assemblies. The company achieved a record order backlog of $132.9 million and generated its fifth consecutive quarter of positive adjusted EBITDA. During the period, the company also completed the sale of its China subsidiary and secured over $30 million in follow-on defense-related orders.
Term
Q1 2027
“Fiscal 2027 is off to a strong start, led by backlog, a key indicator of our expected future revenue trends. New orders significantly outpaced shipments during the first quarter, lifting backlog by $22 million to a record $132.9 million, with approximately $110.8 million of it requested by customers for delivery over the next twelve months.”
Sam Rubin, President and Chief Executive Officer
“The composition of our revenue continues to be more favorable as well. Revenue grew 38% year-over-year to $20.8 million, and assemblies and modules accounted for 51% of the total, up from 40% a year ago. That shift toward higher-value cameras and optical assemblies lifted gross margin to 41.4%, and we generated positive adjusted EBITDA for the fifth consecutive quarter while more than doubling our investment in new product development.”
PC Connection President & COO Matthew David Zafirovski Buys $200K of Stock
Matthew David Zafirovski, President & COO, bought 2,490 shares of PC Connection Inc at $80.20 a share, worth $200K in total on Nov 9, 2026. Shares held after the trade: 2,490.
Peloton Interactive, Inc. priced an upsized private offering of $700 million in 8.625% senior secured notes due 2032 and proposed a new $200 million five-year revolving credit facility. The company intends to use the proceeds to refinance its existing $1.0 billion term loan facility and for general corporate purposes.
Neuronetics Debt Financing Update with Perceptive Credit Holdings IV, LP
Neuronetics entered into Amendment No. 6 to its existing Credit Agreement with Perceptive Credit Holdings IV, LP to modify certain revenue covenants. The amendment is subject to an optional prepayment of at least $15 million plus interest and fees, and will automatically terminate if conditions are not met by November 30, 2026.
National CineMedia reported a net loss of $17.2 million for the third quarter of 2026, compared to a net income of $1.6 million in the prior year period, primarily driven by a $36.4 million loss on the re-measurement of the tax receivable agreement. The company significantly expanded its balance sheet through a $271.1 million business acquisition funded by a new $275.0 million term loan facility.